Sports Medicine and Shoulder Service, Department of Orthopedic Surgery, Hospital for Special Surgery, New York, New York, USA.
Am J Sports Med. 2018 Feb;46(2):487-496. doi: 10.1177/0363546517697690. Epub 2017 Mar 29.
Historically, treatment efficacy of professional baseball injuries has been determined by assessing the return-to-play (RTP) rate or using patient-reported functional outcomes scores; however, these methods may not be sensitive and specific enough for elite athletes. As a consequence, performance-based statistics are increasingly being reported in the medical literature.
To (1) assess how treatment efficacy is currently reported in professional baseball players; (2) examine the variability in the reporting of these measures in terms of frequency, length of time followed, and units of measure; and (3) identify any attempts to validate these performance-based statistics.
Systematic review.
All studies reporting treatment efficacy in professional baseball in PubMed, Embase, and Cochrane were identified. Data collected included frequency and method of reporting: RTP, functional outcomes, and performance-based statistics.
Fifty-four studies met all inclusion criteria. Of these, 51 (94%) reported RTP, 12 (22%) utilized functional outcomes, and 18 (33%) provided baseball-specific performance-based statistics to assess treatment efficacy. Great variability was seen in how follow-up was defined (games, seasons, months), duration of follow-up, and which performance-based statistics were utilized. None of the studies validated these performance-based statistics, determined minimal time of follow-up needed, or assessed the baseline variability in these statistics among noninjured players.
Most studies reported RTP to determine treatment efficacy, but significant variability was seen in how players were followed. Similarly, great variability was noted in the type and number of performance-based statistics utilized. Additional studies are necessary to validate these measures and determine the appropriate length of time that they should be followed.
This study provides a clear overview of the current methods that are used to determine treatment efficacy in professional baseball players.
从历史上看，职业棒球运动员受伤的治疗效果是通过评估重返赛场（RTP）率或使用患者报告的功能结果评分来确定的；然而，这些方法对精英运动员来说可能不够敏感和特异。因此，基于表现的统计数据在医学文献中越来越多地被报道。
（1）评估目前在职业棒球运动员中如何报告治疗效果；（2）根据频率、随访时间和测量单位，检查这些措施报告的变异性；（3）确定对这些基于表现的统计数据进行验证的任何尝试。
系统评价。
在 PubMed、Embase 和 Cochrane 中检索报告职业棒球治疗效果的所有研究。收集的数据包括报告频率和方法：RTP、功能结果和基于表现的统计数据。
54 项研究符合所有纳入标准。其中，51 项（94%）报告了 RTP，12 项（22%）使用了功能结果，18 项（33%）提供了特定于棒球的基于表现的统计数据来评估治疗效果。在随访定义（比赛、赛季、月）、随访持续时间和使用哪些基于表现的统计数据方面存在很大的差异。没有研究验证这些基于表现的统计数据，确定需要随访的最短时间，也没有评估这些统计数据在未受伤运动员中的基线变异性。
大多数研究报告 RTP 来确定治疗效果，但在如何跟踪运动员方面存在显著差异。同样，在使用的基于表现的统计数据的类型和数量上也存在很大差异。需要进一步的研究来验证这些措施，并确定它们应该随访的适当时间。
本研究清楚地概述了目前用于确定职业棒球运动员治疗效果的方法。
